Motley Fool's Kristine Harjes and Todd Campbell discuss whether investors ought to be buying 3 of biotech's worst performing stocks over the past month.

After years of building its subscriber base with a vast library of content, Netflix is making a risky bet that will see it lose thousands of popular movies in favor of exclusive titles. Is the company making another Qwikster-like mistake or preparing itself for a bright, new future?

Should an intangible quality like corporate culture affect how you invest?

Facebook has entered the personal assistant space, announcing testing has begun on “M,” a new digital helper nested in their Messenger app -- what does it say about the company’s plans to monetize Messenger and WhatsApp? In other tech news, new data from IDC shows Apple and Xiaomi are catching up to wearables leader Fitbit. Is the recently public company about to get pinched?

In the midst of popping and dropping markets, the Motley Fool's Kristine Harjes and contributor Todd Campbell tackle what healthcare stocks investors can buy.